09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply. Interested volunteer...
NIAID
Clinical Trial Evaluating Monkeypox Vaccine Begins Highlights from Opening Day of AIDS 2022 07-30-2022Yesterday, as the 24th International AIDS Conference (AIDS 2022) opened, HIV.gov spoke with the White House s Harold Phillips,...Special Issue of JAIDS Highlights HIV Implementation Research in the EHE Initiative 06-13-2022The Ending the HIV Epidemic in the U.S. (EHE) initiative set a goal to virtually eliminate new HIV infections in the U.S. by 2030...Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period 06-02-2022Cross-posted from NIAID Newsroom Strategy May Offer Alternative to Daily AntiretroviralsIndividuals with HIV who began taking anti...NIH Launches Clinical Trial of Three mRNA HIV Vaccines 03-23-2022Cross-posted from NIAID Newsroom Phase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy...HIV Research Update from CROI 2022 with NIH’s Dr. Carl Dieffenbach: Cancer Prevention, Aging, and the Future of HIV Prevention & Treatment 03-01-2022NIH’s Dr. Carl Dieffenbach Discusses Highlights of HIV Cure, Treatment and Prevention Research from CROI 2022 02-17-2022In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach discussed some of the pivotal HIV research advances presented this week at the 2022…Researchers Document Third Known Case of HIV Remission Involving Stem Cell Transplant 02-15-2022Cross-posted from NIAID Newsroom Woman Has Remained Without Detectable HIV for 14 MonthsA woman with HIV who received a cord blood...Watch for Video and Blog Updates from CROI 2022 02-09-2022Next week, for the 11th year in a row, HIV.gov will begin sharing updates on the latest HIV research from the 2022 virtual Confer...Statement—NIH Celebrates FDA Approval of Long-Acting Injectable Drug for HIV Prevention 12-21-2021Cross-posted from NIAID Newsroom Approval Marks Pivotal Expansion of HIV Prevention Options in the United StatesYesterday the U.S....Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals 12-15-2021Cross-posted from the NIAID Newsroom NIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA the sa...Too Many People with HIV Fail to Achieve Durable Viral Suppression 11-30-2021NIH-Funded Study Estimates Global Progress Toward UNAIDS GoalCross-posted from NIAID Newsroom Among people with HIV worldwide who...NIH Awards Support HIV Epidemic Research Teams Working in U.S. Communities 11-12-2021Cross-posted from NIAID Now blog The National Institutes of Health has awarded approximately $16 million to support implementation...HIV Vaccine Candidate Does Not Sufficiently Protect Women Against HIV Infection 09-01-2021Cross-posted from NIAID newsroom No Safety Concerns Found in Imbokodo Sub-Saharan Africa StudyAn investigational HIV vaccine test...NIH Makes Substantial New Investment in HIV Cure Research 08-19-2021Cross-posted from NIAID Newsroom The National Institutes of Health has awarded approximately $53 million in annual funding over th...People with HIV Have High Prevalence of Coronary Plaque Associated with Inflammation, Immune Activation 07-20-2021Adapted from National Institute of Allergy and Infectious Diseases email People with HIV have significantly higher rates of cardio...Videos and Posters Share Lessons from Research Projects in EHE Jurisdictions 07-08-2021Videos and posters are now available from the recent virtual National Ending the HIV Epidemic (EHE) Meeting of the NIH-funded Cen...NIH-Funded Study Tests “One-Stop” Mobile Clinics to Deliver HIV, Substance Use Care 06-16-2021Cross-posted from NIH Newsroom A clinical trial is underway in five U.S. cities to determine whether delivering integrated health...NIAID Observes HIV Vaccine Awareness Day 2021 05-18-2021Cross-posted from NIAID Now blog A researcher prepares to administer an investigational vaccine to a clinical trial participant. C...NIH Announces 3 New Funding Opportunities for Research to Help End the HIV Epidemic in EHE Jurisdictions and with Local Partners 04-28-2021Cross-posted from NIAID Funding News Diagnose. Treat. Prevent. Respond.Such are the four pillars of the Ending the HIV Epidemic (E...